Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on October 2, 2026

Oct. 2, 2026

National Minority Quality Forum Launches “Protect From Day One” RSV Campaign

Indeterminate GlobeNewswire

Oct. 2, 2026

iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

LifeWorks Wellness Center Opens New Facility, Centralizing Care on Main Campus in Clearwater

Indeterminate GlobeNewswire

Oct. 2, 2026

20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

Rodale Institute Honors Marion Nestle with Inaugural Organic Stewardship Award for Lifetime Achievement in Education

Indeterminate GlobeNewswire

Oct. 2, 2026

Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation

Indeterminate GlobeNewswire

Oct. 2, 2026

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

Indeterminate GlobeNewswire

Oct. 2, 2026

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

Indeterminate GlobeNewswire

Oct. 2, 2026

Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients

Indeterminate GlobeNewswire

Oct. 2, 2026

Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome

Indeterminate GlobeNewswire

Oct. 2, 2026

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Indeterminate GlobeNewswire

Oct. 2, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Celcuity Appoints David Gryska To Its Board Of Directors

Indeterminate GlobeNewswire

Oct. 2, 2026

Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics

Indeterminate GlobeNewswire

Oct. 2, 2026

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

Indeterminate GlobeNewswire

Oct. 2, 2026

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Indeterminate GlobeNewswire

Oct. 2, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire